Company
CellFe
We’re dedicated to creating a world where everyone has access to lifesaving cell therapies
Also known as CellFE, Inc.
- Status
- Operatingas of 2026-09-22
- Business model
- B2B
- Customers
- researchers and developers
- Legal name
- CellFE, Inc.
- cellfebiotech.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
The CellFE microfluidic-based gene editing technology maintains cell health, produces high yields, and supports rapid, complex genome editing.
Funding snapshot
- Total raised
- $22MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Series A, $22M
Funding rounds
- Series A
- $22MCompany stated
Products
- Web
- CellFE High Volume Cyva System
- Web
- CellFE High Volume Cyva™ System
- Web
- CellFE T-Rest
- Web
- CellFE T-Rest™
- Hardware
- Ryva Mechanoporation System
- Web
- Ryva Mechanoporation System
- Web
- Ryva™ Mechanoporation System
Loading relationship preview